EGFR blockade confers sensitivity to cabozantinib in hepatocellular carcinoma.

ABSTRACT:

SUBMITTER: Ma X 

PROVIDER: S-EPMC9399229 | biostudies-literature | 2022 Aug

REPOSITORIES: biostudies-literature